Company advances its mission to deliver next-generation diabetes management solutions and expand global market penetration Next-generation column technology enhances efficiency, expands recurring ...
Next-generation column technology enhances efficiency, expands recurring revenue potential, and strengthens Trinity Biotech’s competitive position in the $2B+ HbA1c market DUBLIN, Dec. 15, 2025 (GLOBE ...
Following a recent five-hour drive east from Tucson, the New Mexico desert sky was robin-egg blue, with wildflowers gently opening to the sun’s warmth. I was standing at Trinity, ground zero, where ...
TipRanks on MSN
Trinity Biotech accelerates global rollout of high-capacity HbA1c column system after new regulatory clearances
Trinity Biotech ( ($TRIB) ) just unveiled an update. On December 15, 2025, Trinity Biotech announced that it has secured regulatory clearances in ...
The UK currently has the highest drink drive limit in Europe, one that has remained unchanged since it was first introduced ...
DUBLIN - Trinity Biotech plc (NASDAQ:TRIB) has secured regulatory clearances in multiple countries for its next-generation high-capacity HbA1c column system for the Premier Hb9210 analyzer, the ...
DUBLIN, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback